Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical science

• Publication date

  2012-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1042/CS20110504PMID 22439844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytes.

  2012cited by this paper
• Mechanisms and clinical implications of hepatocyte lipoapoptosis

  2010cited by this paper
• Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

  2010cited by this paper
• Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

  2010cited by this paper
• JNK regulation of hepatic manifestations of the metabolic syndrome.

  2010cited by this paper
• Molecular mechanisms of liver preconditioning.

  2010cited by this paper
• A Silybin-Phospholipid Complex Prevents Mitochondrial Dysfunction in a Rodent Model of Nonalcoholic Steatohepatitis

  2010cited by this paper
• Adenosine signaling contributes to ethanol-induced fatty liver in mice.

  2009cited by this paper
• Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance

  2009cited by this paper
• Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.

  2009cited by this paper
• Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioning.

  2009cited by this paper
• Pan‐caspase inhibitor VX‐166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis

  2009cited by this paper
• c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.

  2009cited by this paper
• Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease

  2008cited by this paper
• p38α MAPK inhibits JNK activation and collaborates with IκB kinase 2 to prevent endotoxin‐induced liver failure

  2008cited by this paper
• Adenosine‐dependent activation of hypoxia‐inducible factor‐1 induces late preconditioning in liver cells

  2008cited by this paper
• Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.

  2008cited by this paper
• Ecto‐5′‐nucleotidase (CD73) ‐mediated extracellular adenosine production plays a critical role in hepatic fibrosis

  2008cited by this paper
• Animal models of NASH: Getting both pathology and metabolic context right

  2008cited by this paper
• Adenosine, an endogenous distress signal, modulates tissue damage and repair

  2007cited by this paper
• Palmitic acid induces production of proinflammatory cytokine interleukin‐8 from hepatocytes

  2007cited by this paper
• Metabolic syndrome and NASH.

  2007cited by this paper
• Adenosine A2A Receptor Occupancy Stimulates Collagen Expression by Hepatic Stellate Cells via Pathways Involving Protein Kinase A, Src, and Extracellular Signal-Regulated Kinases 1/2 Signaling Cascade or p38 Mitogen-Activated Protein Kinase Signaling Pathway

  2007cited by this paper
• Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes.

  2006cited by this paper
• Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

  2006cited by this paper
• Analysis of apoptosis by propidium iodide staining and flow cytometry

  2006cited by this paper
• Jnk1 but not jnk2 promotes the development of steatohepatitis in mice

  2006cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease

  2005cited by this paper
• Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning.

  2004cited by this paper
• Akt (Protein Kinase B) Negatively Regulates SEK1 by Means of Protein Phosphorylation*

  2002cited by this paper
• The phosphoinositide 3-kinase pathway.

  2002cited by this paper
• Nonalcoholic steatohepatitis.

  2001cited by this paper
• Signal transduction by the JNK group of MAP kinases.

  2000cited by this paper
• Centrilobular and perisinusoidal fibrosis in experimental congestive liver in the rat.

  1999cited by this paper
• Protective effect of preconditioning on the injury associated to hepatic ischemia‐reperfusion in the rat: Role of nitric oxide and adenosine

  1997cited by this paper

• Adenosine A2AR agonist blocks mesenteric lymphatic epithelium, adipose tissue and Treg cells links of metabolic dysfunction-associated steatotic liver disease mice.

  2025cites this paper
• Inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine A2AR improves hepatic and cardiac dysfunction of NASH mice

  2024cites this paper
• Purinergic Signaling in Non-Parenchymal Liver Cells

  2024cites this paper
• The different effects of four adenosine receptors in liver fibrosis

  2024cites this paper
• Knockout of Purinergic P2Y6 Receptor Fails to Improve Liver Injury and Inflammation in Non-Alcoholic Steatohepatitis

  2023cites this paper
• Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma

  2023cites this paper
• Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)

  2022cites this paper
• MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis

  2022influential citation
• Adenosine A2a Receptor Regulates Autophagy Flux and Apoptosis to Alleviate Ischemia-Reperfusion Injury via the cAMP/PKA Signaling Pathway

  2022cites this paper
• Exercise inhibits JNK pathway activation and lipotoxicity via macrophage migration inhibitory factor in nonalcoholic fatty liver disease

  2022cites this paper
• CD73‐generated extracellular adenosine promotes resolution of neutrophil‐mediated tissue injury and restrains metaplasia in pancreatitis

  2022cites this paper
• Hepatocyte Adenosine Kinase Promotes Excessive Fat Deposition and Liver Inflammation.

  2022cites this paper
• Pathophysiology roles for adenosine 2A receptor in obesity and related diseases

  2022influential citation
• Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP‐Activated Protein Kinase Signaling Pathway

  2021cites this paper
• Role of CD4+ T-cells in the pathology of non-alcoholic fatty liver disease and related diseases

  2021cites this paper
• DUSP12 acts as a novel endogenous protective signal against hepatic ischemia–reperfusion damage by inhibiting ASK1 pathway

  2021cites this paper
• Purinergic Signaling in Liver Pathophysiology

  2021cites this paper
• Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities

  2020cites this paper
• Purinergic signaling in diabetes and metabolism.

  2020cites this paper
• The role of the CD39–CD73–adenosine pathway in liver disease

  2020cites this paper
• Purinergic signaling in hepatic disease

  2019cites this paper
• Mice lacking adenosine 2A receptor reveal increased severity of MCD-induced NASH.

  2019cites this paper
• Regulation of adipose tissue inflammation by adenosine 2A receptor in obese mice.

  2018cites this paper
• Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity

  2018cites this paper
• A2a adenosine receptor agonist improves endoplasmic reticulum stress in MIN6 cell line through protein kinase A/ protein kinase B/ Cyclic adenosine monophosphate response element‐binding protein/ and Growth Arrest And DNA‐Damage‐Inducible 34/ eukaryotic Initiation Factor 2α pathways

  2018cites this paper
• Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity

  2017cites this paper
• Purinergic Signalling: Therapeutic Developments

  2017cites this paper
• Oxidative and ER stress-dependent ASK1 activation in steatotic hepatocytes and Kupffer cells sensitizes mice fatty liver to ischemia/reperfusion injury.

  2017cites this paper
• Metabolic Syndrome and the Liver

  2016cites this paper
• In Situ Evaluation of Oxidative Stress in Rat Fatty Liver Induced by a Methionine- and Choline-Deficient Diet

  2016cites this paper
• Potent irreversible P2Y12 inhibition does not reduce LPS-induced coagulation activation in a randomized, double-blind, placebo-controlled trial.

  2016cites this paper
• The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice.

  2016cites this paper
• Mouse hepatocytes and LSEC proteome reveal novel mechanisms of ischemia/reperfusion damage and protection by A2aR stimulation.

  2015cites this paper
• CD73 regulates vascular smooth muscle cell functions and facilitates atherosclerotic plaque formation

  2015cites this paper
• Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype

  2015cites this paper
• Nouvelle Cuisine: Platelets Served with Inflammation

  2015cites this paper
• Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.

  2014cites this paper
• Purinergic signalling in the liver in health and disease

  2014cites this paper
• Nonalcoholic fatty liver disease: current and potential therapies.

  2013cites this paper
• Ursodeoxycholyl Lysophosphatidylethanolamide Inhibits Lipoapoptosis by Shifting Fatty Acid Pools toward Monosaturated and Polyunsaturated Fatty Acids in Mouse Hepatocytes

  2013cites this paper
• Non‐alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches

  2013cites this paper
• Adenosine A(2A) receptor activation supports an atheroprotective cholesterol balance in human macrophages and endothelial cells.

  2013cites this paper
• Direct renin inhibitor, aliskiren, attenuates the progression of non‐alcoholic steatohepatitis in the rat model

  2013cites this paper
• Proof Delivery Form

  2012cites this paper
• Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.

  2012influential citation
• Regulatory effects of TLR2 on megakaryocytic cell function.

  2011cites this paper
• Megakaryocyte TLR2: immunity bullet?

  2011cites this paper